Carlsmed announced today that it raised $52.5 million in a Series C funding round co-led by B Capital and U.S. Venture Partners. The Carlsbad, California-based AI-enabled personalized surgery company plans to use the funds to accelerate commercialization efforts. It wants to boost the commercialization of its aprevo personalized spine surgery platform for lumbar fusion procedures, […]
Spine
Medtronic launches intelligent data collection tech for spine surgery
Medtronic announced that it launched its UNiD ePRO service in the U.S. to provide electronic patient-reported outcomes (PROs) to spine surgeons. The medtech giant believes its service, created through a partnership with OBERD, could change patient outcome collection. With OBERD, a practice intelligence data collection company, Medtronic hopes to reduce the burden on clinical staff […]
Orthofix beats Street in Q4, analysts see positive signs for future
Orthofix Medical are up today on fourth-quarter results that topped the consensus forecast. The Lewisville, Texas–based company posted losses of $22.2 million in the quarter. That equals 59¢ per share on sales of $200.4 million for the three months ended Dec. 31, 2023. The company’s bottom line dipped by more than $15 million further into […]
Medtronic may face jury trial in spine implants case
A nearly decade-old whistleblower suit against Medtronic — involving FDA clearance of spine fusion devices — is moving forward. In an order dated Feb. 16, U.S. District Court Judge John Kronstadt in Central California denied Medtronic’s motion for summary judgment in the case filed by The Dan Abrams Co. LLC. The LLC’s sole employee, Bryan […]
Orthofix announces new president of Bone Growth Therapies
Orthofix Medical (NASDAQ:OFIX) is promoting from within to fill a new business president position at the company. The Lewisville, Texax–base spine and ortho tech company announced today that it moving its Bone Growth Therapies business out from under the leadership of its Spine business. Jason Shallenberger, previously the VP of U.S. sales and marketing for […]
FDA clears sacroiliac joint fusion device from Nevro
Nevro (NYSE:NVRO) announced today that the FDA cleared its sacroiliac (SI) joint fusion device without the need to include an accompanying screw. Redwood City, California-based Nevro plans to market this device as Nevro1, without the need for the NevroFix screw. The system aims to immediately transfix the SI joint, allowing the opportunity for long-term fusion. […]
Former Mazor VP convicted of insider trading
A federal jury in Minnesota has convicted a former Mazor Robotics VP of insider trading and securities fraud around Medtronic’s $1.6 billion acquisition announcement in 2018. Ron Tavlin was Mazor’s VP of business development from 2017 to 2019. Before that, he’d been a paid consultant for Medtronic. On Feb. 16, a jury found him guilty on […]
Wandercraft wins FDA clearance for exoskeleton for people with spinal cord injuries
Wandercraft announced today that it received FDA clearance for its Atalante X exoskeleton for individuals with spinal cord injuries (SCIs). The FDA granted clearance for people with SCIs at levels T5 to L5 to utilize the self-balancing robotic exoskeleton technology. The system enables those with limited mobility to stand up and walk again. Wandercraft says […]
Accelus adds duo of directors to its board
Spine implant developer Accelus announced today that it appointed Kevin McGann and Bernie Haffey to its board of directors. The Palm Beach Gardens, Florida-based company said the new appointments provide a strategic enhancement and align with its mission. Accelus aims to deliver innovative spinal solutions that elevate the surgical experience and improve patient outcomes. It […]
Globus Medical promotes new COO from within
Globus Medical announced that it promoted CFO Keith Pfeil to the position of chief operating officer (COO). Pfeil first took over the CFO post in August 2019. Globus Medical hopes his new expanded role can help further drive its strategic roadmap through business and operational planning in addition to financial performance management. He continues reporting […]
FDA expands approval for Boston Scientific spinal cord stim to include chronic back pain without prior back surgery
Boston Scientific announced today that the FDA approved an expanded indication for its WaveWriter spinal cord stimulation (SCS) systems. The indication covers chronic low back and leg pain in people without prior back surgery — called non-surgical back pain (NSBP). Boston Scientific says first-line treatment for people with chronic back pain tends to have limitations. […]